Vitrification of tissue engineered pancreatic substitute.
Despite significant advances, some critical issues remain for the long-term storage of an engineered pancreas. In this study we employed a tissue engineered pancreatic substitute model-insulin-secreting betaTC3 cells entrapped in calcium alginate/poly-L-lysine/alginate beads-to demonstrate that a prototype vitrification method can prevent ice formation and maintain cell viability/function. The results showed that the structure of the frozen samples was distorted by ice crystals throughout the matrix. In marked contrast, the vitrified samples appeared to be free of ice. Morphologic studies demonstrated extensive fractures and vacuolation in frozen specimens while there were no fractures in vitrified TEPSs. Both vitrified and frozen constructs showed some vacuolization compared to the control samples. Frozen beads showed a significantly decreased viability compared to fresh controls and the VS55 group (P < .001). There was no significant difference between the vitrified and fresh samples. Vitrification using the VS55 protocol shows similar viability and secretion properties to the control group of fresh beads. Vitrification using the PEG 400 protocol resulted in slightly lower viability and secretion properties relative to the control group; conventional freezing resulted in even significantly lower viability and secretion properties. These results combine to demonstrate feasibility of vitrification as a storage method for a tissue engineered pancreas.
Song
Y C
YC
Organ Recovery Systems, Inc., Charleston, South Carolina 29403, USA. ysong@organ-recovery.com
Chen
Z Z
ZZ
Mukherjee
N
N
Lightfoot
F G
FG
Taylor
M J
MJ
Brockbank
K G
KG
Sambanis
A
A
D000818:Animals; D015925:Cryopreservation; D004121:Dimethyl Sulfoxide; D005559:Formamides; D005947:Glucose / Q000494:pharmacology; D007202:Indicators and Reagents; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D019188:Organ Preservation Solutions; D023822:Tissue Engineering / Q000379:methods*; D014021:Tissue Preservation / Q000379:methods*
D005559:Formamides; D007202:Indicators and Reagents; D007328:Insulin; D019188:Organ Preservation Solutions; C031066:formamide; D005947:Glucose; D004121:Dimethyl Sulfoxide